SCHEMBL26647596

SCHEMBL26647596

CC(=O)c1ccc(-c2cc(N3CCC(O)CC3)nc(Nc3nc(C)c(C(=O)O)s3)n2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 6/20 0.58
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CCNT1 O60563 1/20 0.39
▸ CDK4 P11802 1/20 0.39
▸ CCND1 P24385 1/20 0.39
▸ CDK9 P50750 1/20 0.39
▸ CDK6 Q00534 1/20 0.39
▸ CDK11A Q9UQ88 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ PTGER4 P35408 2/20 0.37
▸ FGFR1 P11362 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ PPARG P37231 1/20 0.37
▸ NR2E3 Q9Y5X4 1/20 0.37
▸ NCOR2 Q9Y618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27950930 0.91 PDE5A (0.61) PDE5AALDH1A1HPGDCCNT1CDK4
SCHEMBL27937575 0.91 PDE5A (0.60) PDE5AALDH1A1HPGDCCNT1CDK4
SCHEMBL27950936 0.90 PDE5A (0.59) PDE5AALDH1A1HPGDCCNT1CDK4
SCHEMBL2680309 0.89 PDE5A (0.76) PDE5AALDH1A1HPGDLMNAMAPT
SCHEMBL27937611 0.89 PDE5A (0.71) PDE5AALDH1A1HPGDLMNAMAPT
SCHEMBL27950964 0.89 PDE5A (0.62) PDE5AALDH1A1HPGDCCNT1CDK4
SCHEMBL27937605 0.88 PDE5A (0.59) PDE5AALDH1A1HPGDCCNT1CDK4
SCHEMBL27950958 0.87 PDE5A (0.56) PDE5AALDH1A1HPGDCCNT1CDK4
SCHEMBL26647667 0.86 XDH (0.52) PDE5AALDH1A1HPGDCCNT1CDK4
SCHEMBL20559620 0.86 PDE5A (0.76) PDE5AALDH1A1HPGDCCNT1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4275752-A2 TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS Omeros Corporation (US) 2023-11-15 — — EP disclosed
CN-103547267-A Treatment of addiction and impulse control disorders using PDE7 inhibitors OMEROS CORP 2014-01-29 — — CN disclosed
Send feedback